Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

Korean Medication Algorithm for Bipolar Disorder 2006(IV): Rapid Cycling

Jon DI, Bahk WM, Lee E, Yoon BH, Chung SK, Kim W, Shin YC, Cho HS, Kwon JS, Seo JS, Ha KS, Min KJ

  • KMID: 2287140
  • Korean J Psychopharmacol.
  • 2006 Sep;17(5):449-455.
OBJECTIVE: The development of treatment guidelines has emerged as an important element so as to standardize treatment and to provide clinicians with algorithms. From the previous publication of Korean Medication...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neurohormonal Dysregulations in Schizophrenia

Jeong JH, Hong SC, Bahk WM

  • KMID: 2287136
  • Korean J Psychopharmacol.
  • 2006 Sep;17(5):415-422.
Endocrinological studies of mental disorder are based on the fact that the neuroendocrinological system is under central nervous system control, thus linking peripheral hormonal secretion and brain activity. Neuroendocrine basis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lithium Potentiates the FeCl2 Induced Free Radical Injury in Primary Mouse Cortical Cell Culture

Lee SH, Lee YA, Byun HY, Gwag BJ, Chung YK, Noh JS

  • KMID: 2287143
  • Korean J Psychopharmacol.
  • 2006 Sep;17(5):468-474.
OBJECTIVES: For the past half century, lithium has been used for the acute and prophylactic treatment of bipolar disorder and recurrent depression. Recently, new pharmacological effects of Li+ have appeared,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Bipolar Diathesis in Patients with Treatment Resistant Depression

Woo YS, Chae JH, Seo HJ, Song HR, Jun TY, Kim KS, Bahk WM

  • KMID: 2287141
  • Korean J Psychopharmacol.
  • 2006 Sep;17(5):456-460.
OBJECTIVE: In this study, we determined the prevalence of bipolarity in patients with treatment resistant depression (TRD) by investigating demographic and clinical characteristics, diagnostic subtypes, and illness outcome. METHOD: A medical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Correlation between Plasma Ghrelin Levels and Risperidone Induced Weight Gain

Lee CS, Kim EH, Park CS, Kim BJ

  • KMID: 2287138
  • Korean J Psychopharmacol.
  • 2006 Sep;17(5):429-435.
OBJECTIVES: Although enhanced appetite and weight gain are potential side effects of treatment with antipsychotic agents, the mechanism is poorly understood. Ghrelin is a newly discovered appetite-stimulating peptide that has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm for Bipolar Disorder 2006(III): Depressive Episode

Min KJ, Bahk WM, Seo JS, Ha KS, Jon DI, Lee E, Kwon JS, Chung SK, Yoon BH, Kim W, Shin YC, Cho HS

  • KMID: 2287139
  • Korean J Psychopharmacol.
  • 2006 Sep;17(5):436-448.
OBJECTIVE: In 2002, the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP 2002) was published to make clinical guidelines to understand and treat bipolar disorder, but due to recent reports...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association Study of -2548A/G Polymorphism of Leptin Gene with Antipsychotics-Induced Weight Gain

Ryu S, Jang WS, Cho EY, Kim SK, Lee D, Hong KS

  • KMID: 2287137
  • Korean J Psychopharmacol.
  • 2006 Sep;17(5):423-428.
OBJECTIVES: Leptin, the product of ob gene, is secreted by adipocytes and signals the size of peripheral fat stores to the brain. Several evidences indicate that a polymorphism in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Preliminary Study of the Efficacy and Safety of Bupropion as the Second-Line Drug in Children with Attention Deficit Hyperactivity Disorder

Park S, Kim JY, Choi SH, Yoo HK, Hong JP, Kim SY, Kim CY

  • KMID: 2287142
  • Korean J Psychopharmacol.
  • 2006 Sep;17(5):461-467.
OBJECTIVES: This study was aimed to examine the efficacy and safety of bupropion in methylphenidate-inapplicable children with attention deficit hyperactivity disorder (ADHD) due to insufficient treatment response or intolerable adverse...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
MRI Structure and Histological Change of Rat after Memantine Intake in Olfactory Bulbectomised Depression Model

Kim SY, Lee YS, Kee BS, Min KJ, Yoon HG, Yu H, Nam TK

  • KMID: 2287144
  • Korean J Psychopharmacol.
  • 2006 Sep;17(5):475-484.
OBJECTIVE: The validity of olfactory bulbectomized rat as an animal depression model and the possibilities of the NMDA antagonist as an antidepressant would be evaluated by demonstrating structural alterations in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr